The FDA approved the combination pill, Epclusa, from Gilead Sciences for patients with and without liver damage. » Read More
These days the most cash-rich companies often sell mobile phones rather than mortgages. Cramer tells you who's who in the changing market landscape.
Stocks ended higher Tuesday, snapping a three-day losing streak, after strong earnings from Merck and a better-than-expected housing report lifted sentiment on the Street.
Stocks ended higher Tuesday, snapping a three-day losing streak, as an earnings beat from Merck and better-than-expected housing report gave the market a boost.
As of this morning afternoon, nearly 50% of the S&P 500 companies have reported earnings. Here's a look at which companies have had the biggest surprises so far...
The health care sector today just went positive for 2009, making it the only major industry group to currently be in the green for this young year.
Stocks had a topsy-turvy morning as investors digested a revival in pending-home sales and an earnings beat from Merck against some gloomy news out of the tech sector.
Before Gardasil came to market two to three years ago, some analysts were saying it would become the biggest-selling vaccine in history. But hope and reality have turned out to be two different things.
Overseas markets are mixed this morning. Australia cut its interest rates to a record low 3.25 percent and unveiled a stimulus plan, while the Bank of Japan said it would buy up to $11 billion of shares held by banks.
US stock index futures struggled to find direction ahead of the open Tuesday, following a mixed close for stocks Monday, as investors feared the government stimulus plan may not provide the catalyst they hoped for.
The guys go behind the headlines and give you their take on the dismal economics numbers that capped off the worst January ever. But there are still places where you can make fast money.
Stocks declined as uncertainty about the government's so-called "bad bank" plan rattled the market.
Investors can’t help but wonder what’s the best way to play Pharma after Pfizer said it would buy rival Wyeth for $60 billion, a 20% premium!
Ever wonder how these people decide which stock's a buy and which is a sell? Now you know.
Dr. Steven Nissen, the cardiology chief at the Cleveland Clinic, reportedly remains on the shortlist to possibly become the next FDA Commissioner. Some analysts believe if Dr. Nissen gets the nod there could be a negative knee-jerk reaction in the big pharma sector stocks.
The Dow ended below 8,000 for the first time in two months as bank stocks took a beating over profit worries.
Stocks paused briefly as Barack Obama was sworn in as the 44th president but resumed their slide as banks took a beating over profit worries.
The FDA giveth and the FDA taketh away. Yesterday the agency handed Merck a little bit of a break with what could be interpreted as an endorsement, of sorts. But then this morning the FDA issued another delay in deciding whether to approve the company's Gardasil vaccine.
It’s Beijing, and not Washington, that’s going to get us out of this worldwide recession, he says.
Merck, Lilly and Pfizer are all trading substantially higher. Will this bear market remedy keep working in the new year?
Stocks finished higher Friday on a day when Wall Street looked like a ghost town, but the week ended without a visit from a much-anticipated Santa Claus rally.